0001193805-20-000879.txt : 20200722 0001193805-20-000879.hdr.sgml : 20200722 20200722160546 ACCESSION NUMBER: 0001193805-20-000879 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200720 FILED AS OF DATE: 20200722 DATE AS OF CHANGE: 20200722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vitt Daniel CENTRAL INDEX KEY: 0001773673 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36201 FILM NUMBER: 201041568 MAIL ADDRESS: STREET 1: IMMUNIC AG STREET 2: AM KLOPFERSPITZ 19 CITY: MARTINSRIED STATE: 2M ZIP: 82152 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNIC, INC. CENTRAL INDEX KEY: 0001280776 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562358443 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: AM KLOPFERSPITZ 19 CITY: MARTINSRIED STATE: 2M ZIP: 82152 BUSINESS PHONE: 49 89 250079460 MAIL ADDRESS: STREET 1: AM KLOPFERSPITZ 19 CITY: MARTINSRIED STATE: 2M ZIP: 82152 FORMER COMPANY: FORMER CONFORMED NAME: VITAL THERAPIES INC DATE OF NAME CHANGE: 20040219 4 1 e619799_4-vitt.xml X0306 4 2020-07-20 0 0001280776 IMMUNIC, INC. IMUX 0001773673 Vitt Daniel 1200 AVENUE OF THE AMERICAS, SUITE 200 NEW YORK NY 10036 1 1 0 0 Chief Executive Officer Common Stock 2020-07-20 4 S 0 5000 14.4401 D 364177 I See footnote Common Stock 2020-07-21 4 S 0 1300 15.6229 D 362877 I See footnote These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Plan"). The Plan was adopted in connection with certain tax liabilities related to the issuance of shares in the April 2019 exchange transaction between the Issuer (then known as Vital Therapies, Inc.) and Immunic AG. The Reporting Person is Managing Director of Listrax UG (haftungsbeschrankt), which is the record holder of 362,877 shares of common stock of the Issuer, and exercises voting and dispositive power over such shares. /s/ Daniel Vitt 2020-07-22